Emerald Health Therapeutics Stock News

Healthcare > Drug Manufacturers - Specialty & Generic

Buy EMHTF

*Your capital is at risk

$0.0358

+0 (+0%)

At Close: Feb 10, 2023

Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest & Achieves Pivotal Milestone in Transforming its Business

08:33am, Monday, 02'nd Nov 2020

Vancouver, British Columbia--(Newsfile Corp. - November 2, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has completed the previously disclosed sale of its 41

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by